Skip to content
OpenCapital
Get started

Envoy Medical COCH EV / sales

EV / sales at other companies

Inspire Medical Systems logo
Inspire Medical SystemsINSP
1.5×-4.1×

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K—
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+83.5%
P/S260.7×+111×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%—
Debt / equity0.1×—
Current ratio2.3×+1.2×

Where this comes from

Calculated from Envoy Medical’s reported figures.

enterprise value/total revenue=67.7×

Based on the most recent quarter.

The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's EV / sales?
Envoy Medical (COCH) reported EV / sales of 67.7× in Q4 2025.
How has Envoy Medical's EV / sales changed year-over-year?
Envoy Medical's EV / sales decreased by 37.6% year-over-year, from 108.5× to 67.7×.
What is the long-term trend for Envoy Medical's EV / sales?
Over 2 years (2023 to 2025), Envoy Medical's EV / sales has grown at a -18.1% compound annual growth rate (CAGR), from 100.9× to 67.7×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.